Literature DB >> 11422139

Eosinophilic rhinitis accompanies the development of lower airway inflammation and hyper-reactivity in sensitized mice exposed to aerosolized allergen.

P W Hellings1, E M Hessel, J J Van Den Oord, A Kasran, P Van Hecke, J L Ceuppens.   

Abstract

BACKGROUND: Allergic rhinitis is a risk factor for the development of asthma. About 80% of asthmatic patients also have rhinitis. However, the pattern of induction of allergic rhinitis and asthma remains unclear.
OBJECTIVE: The purpose of this study was to investigate the development of upper airway inflammation in mice during the development of an asthma-like disease and after an acute allergen provocation.
METHODS: BALB-c mice were sensitized intraperitoneally (i.p) to ovalbumin (OA, days 1-13) and were challenged with aerosols of either OA or saline on 8 consecutive days (days 33-40). In a second experiment, chronic exposure for 8 days was followed by 10 days of rest and then an acute nebulized allergen provocation was performed (day 50). Inflammatory parameters were investigated at different time-points.
RESULTS: Upper and lower eosinophilic airway inflammation were simultaneously induced in the course of repeated inhalations of nebulized OA, as shown by analyses of nasal and broncho-alveolar lavage fluids and histological sections of the nose and bronchi. Mice that developed bronchial hyper-responsiveness also had increased thickness of the nasal mucosa on magnetic resonance image (MRI) scans. When chronic exposure was followed by acute allergen provocation, the latter caused a systemic increase in IL-5 levels, with a concomitant rise in blood and airway eosinophils, primarily in the nose.
CONCLUSIONS: Simultaneous induction of eosinophilic inflammation in the nose and lungs was found in a mouse model of respiratory allergy. These findings support the viewpoint that upper and lower airway disease represent a continuum of inflammation involving one common airway and provide evidence for the concept of global airway inflammation after inhalation of allergen.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11422139     DOI: 10.1046/j.1365-2222.2001.01081.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  12 in total

1.  Haemopoietic mechanisms in murine allergic upper and lower airway inflammation.

Authors:  Jing Li; Hiroko Saito; Lynn Crawford; Mark D Inman; Michael M Cyr; Judah A Denburg
Journal:  Immunology       Date:  2005-03       Impact factor: 7.397

2.  Rectal administration of lipopolysaccharide and ovalbumin ameliorates acute murine colitis.

Authors:  Jong Pil Im; Byong Duk Ye; Jung Mogg Kim; Hyun Chae Jung; In Sung Song; Joo Sung Kim
Journal:  Dig Dis Sci       Date:  2011-02-26       Impact factor: 3.199

Review 3.  Nasobronchial interaction.

Authors:  Cemal Cingi; Nuray Bayar Muluk; Bengu Cobanoglu; Tolgahan Çatli; Oğuzhan Dikici
Journal:  World J Clin Cases       Date:  2015-06-16       Impact factor: 1.337

4.  Tryptophan metabolite-regulated Treg responses contribute to attenuation of airway inflammation during specific immunotherapy in a mouse asthma model.

Authors:  Qi Hu; Ling Jin; Jing Zeng; Jinyu Wang; Shimin Zhong; Wenting Fan; Wei Liao
Journal:  Hum Vaccin Immunother       Date:  2020-01-17       Impact factor: 3.452

5.  An intratracheal challenge murine model of asthma: can bronchial inflammation affect the nose?

Authors:  Jiaxing Xie; Yin Xi; Qingling Zhang; Guoqin Chen; Luo Wei; Kefang Lai; Nanshan Zhong
Journal:  Allergy Asthma Immunol Res       Date:  2014-10-17       Impact factor: 5.764

6.  The Role of IL-17 in a Lipopolysaccharide-Induced Rhinitis Model.

Authors:  Jun Sang Bae; Ji Hye Kim; Eun Hee Kim; Ji Hun Mo
Journal:  Allergy Asthma Immunol Res       Date:  2017-03       Impact factor: 5.764

7.  Human pluripotent stem cell-derived mesenchymal stem cells prevent allergic airway inflammation in mice.

Authors:  Yue-Qi Sun; Meng-Xia Deng; Jia He; Qing-Xiang Zeng; Weiping Wen; David S H Wong; Hung-Fat Tse; Geng Xu; Qizhou Lian; Jianbo Shi; Qing-Ling Fu
Journal:  Stem Cells       Date:  2012-12       Impact factor: 6.277

8.  Improvement of eosinophilic otitis media by optimized asthma treatment.

Authors:  Yukako Tanaka; Manabu Nonaka; Yukie Yamamura; Etsuko Tagaya; Ruby Pawankar; Toshio Yoshihara
Journal:  Allergy Asthma Immunol Res       Date:  2013-04-01       Impact factor: 5.764

9.  Immunomodulatory effects of Escherichia coli ATCC 25922 on allergic airway inflammation in a mouse model.

Authors:  Wenhui Pang; Hefeng Wang; Lei Shi; Yueqi Sun; Xiaoting Wang; Mingming Wang; Jianfeng Li; Haibo Wang; Guanggang Shi
Journal:  PLoS One       Date:  2013-03-25       Impact factor: 3.240

10.  Systemic and local eosinophil inflammation during the birch pollen season in allergic patients with predominant rhinitis or asthma.

Authors:  Mary Kämpe; Gunnemar Stålenheim; Christer Janson; Ingrid Stolt; Marie Carlson
Journal:  Clin Mol Allergy       Date:  2007-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.